Sonoscape Medical (SZSE:300633) Total Liabilities : ¥787 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Sonoscape Medical Total Liabilities?

Sonoscape Medical's Total Liabilities for the quarter that ended in Mar. 2024 was ¥787 Mil.

Sonoscape Medical's quarterly Total Liabilities declined from Sep. 2023 (¥654.09 Mil) to Dec. 2023 (¥625.46 Mil) but then increased from Dec. 2023 (¥625.46 Mil) to Mar. 2024 (¥787.31 Mil).

Sonoscape Medical's annual Total Liabilities increased from Dec. 2021 (¥665.18 Mil) to Dec. 2022 (¥804.43 Mil) but then declined from Dec. 2022 (¥804.43 Mil) to Dec. 2023 (¥625.46 Mil).

Sonoscape Medical Total Liabilities Historical Data

The historical data trend for Sonoscape Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoscape Medical Total Liabilities Chart

Sonoscape Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,010.11

941.65

665.18

804.43

625.46

Sonoscape Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															762.79	692.69	654.09	625.46	787.31

Sonoscape Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sonoscape Medical's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	568.625	+	(34.007	+	22.831
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	625

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3771.417	-	3145.954
	=	625

Sonoscape Medical's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	731.634	+	(32.42	+	23.252
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	787

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	4043.654	-	3256.348
	=	787

Sonoscape Medical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sonoscape Medical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sonoscape Medical (SZSE:300633) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonoscape Medical Corp (SZSE:300633) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuquan Road, 10th Floor,Yizhe Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518051

Website

http://www.sonoscape.com

Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.

Executives

Zhou Wen Ping	Directors, executives
Huang Yi Bo	Directors, executives
Li Hao	Directors, executives
Chen Zhi Qiang	Director
Wu Kun Xiang	Directors, executives
Liu Ying Fang	Director

Sonoscape Medical (SZSE:300633) Headlines

No Headlines